D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
PUT
Bilibili
BILI
$7.75B
| $2.55M | ﹤0.01% |
140,800
-92,000
| -40% | -$1.93M |
|
2402
Northern Trust
NTRS
$21.8B
| $2.55M | ﹤0.01% |
24,870
-245,573
| -91% | -$25.1M |
|
|
NLOP
2403
Net Lease Office Properties
NLOP
$175M
| $2.55M | ﹤0.01% |
81,627
+1,605
| +2% | +$49.9K |
|
2404
UL Solutions
ULS
$18.6B
| $2.54M | ﹤0.01% |
50,863
+7,294
| +17% | +$378K |
|
2405
PUT
Realty Income
O
$61.1B
| $2.54M | ﹤0.01% |
47,500
+42,300
| +813% | +$2.46M |
|
2406
Fate Therapeutics
FATE
$275M
| $2.54M | ﹤0.01% |
1,536,633
-1,841,017
| -55% | -$4.64M |
|
2407
Diageo
DEO
$49.6B
| $2.53M | ﹤0.01% |
19,930
+11,831
| +146% | +$1.51M |
|
2408
Invesco PHLX Semiconductor ETF
SOXQ
$2.11B
| $2.53M | ﹤0.01% |
+64,567
| New | +$2.59M |
|
2409
Bank of Hawaii
BOH
$3.14B
| $2.53M | ﹤0.01% |
35,546
+29,114
| +453% | +$2.1M |
|
2410
Anika Therapeutics
ANIK
$215M
| $2.53M | ﹤0.01% |
153,764
-297
| -0.2% | -$5.86K |
|
2411
XPO
XPO
$23.4B
| $2.52M | ﹤0.01% |
19,232
-13,468
| -41% | -$1.82M |
|
|
AMTM
2412
Amentum Holdings
AMTM
$5.33B
| $2.52M | ﹤0.01% |
119,936
+33,546
| +39% | +$867K |
|
2413
CALL
Clorox
CLX
$12B
| $2.52M | ﹤0.01% |
15,500
+14,000
| +933% | +$2.29M |
|
|
JACS.U
2414
Jackson Acquisition Co II Units
JACS.U
| $2.52M | ﹤0.01% |
+250,000
| New | +$2.51M |
|
2415
PUT
Campbell Soup
CPB
$6.85B
| $2.51M | ﹤0.01% |
60,000
| – | – |
|
|
EURK
2416
Eureka Acquisition Corp
EURK
$26.5M
| $2.51M | ﹤0.01% |
247,500
+47,500
| +24% | +$480K |
|
2417
CALL
LyondellBasell Industries
LYB
$19.5B
| $2.51M | ﹤0.01% |
+33,800
| New | +$2.84M |
|
2418
Myers Industries
MYE
$1.24B
| $2.51M | ﹤0.01% |
227,283
+202,805
| +829% | +$2.44M |
|
|
DFS
2419
DELISTED
Discover Financial Services
DFS
| $2.51M | ﹤0.01% |
14,484
-10,216
| -41% | -$1.68M |
|
2420
CALL
Murphy USA
MUSA
$11.4B
| $2.51M | ﹤0.01% |
5,000
-1,400
| -22% | -$715K |
|
2421
iShares MSCI Taiwan ETF
EWT
$9.13B
| $2.5M | ﹤0.01% |
+48,345
| New | +$2.62M |
|
2422
Alto Ingredients
ALTO
$338M
| $2.5M | ﹤0.01% |
1,601,379
+274,918
| +21% | +$431K |
|
2423
CALL
Lumen
LUMN
$6.43B
| $2.49M | ﹤0.01% |
468,300
+396,000
| +548% | +$2.73M |
|
2424
PUT
Yeti Holdings
YETI
$3.87B
| $2.47M | ﹤0.01% |
64,100
+52,800
| +467% | +$2.1M |
|
2425
Ormat Technologies
ORA
$5.8B
| $2.47M | ﹤0.01% |
36,438
-111
| -0.3% | -$8.57K |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.